Calidi Biotherapeutics Inc. (CLDI) — Cash Flow-to-Debt Ratio
Calidi Biotherapeutics Inc. (CLDI) has a Cash Flow-to-Debt Ratio of -0.99x as of December 2025, meaning its operating cash flow of $-5.04 Million could theoretically repay -1% of its total liabilities ($5.10 Million) in one year. See how liquid is Calidi Biotherapeutics Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Calidi Biotherapeutics Inc. Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Calidi Biotherapeutics Inc. across 6 annual periods. Also explore net asset growth rate of Calidi Biotherapeutics Inc. to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Calidi Biotherapeutics Inc. (2020–2025)
Year-by-year debt coverage analysis for Calidi Biotherapeutics Inc.. For market capitalisation and broader financial context, see Calidi Biotherapeutics Inc. (CLDI) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.18x | $-21.29 Million | $5.10 Million | ▼ -159.0% |
| 2024 | -1.61x | $-19.69 Million | $12.21 Million | ▼ -9.1% |
| 2023 | -1.48x | $-26.98 Million | $18.25 Million | ▼ -493.3% |
| 2022 | -0.25x | $-13.21 Million | $53.04 Million | ▲ +16.7% |
| 2021 | -0.30x | $-7.77 Million | $26.00 Million | ▼ -50.7% |
| 2020 | -0.20x | $-4.83 Million | $24.33 Million | — |